Can concurrent rifampin use reduce famciclovir's efficacy?

Rifampin can indeed reduce the effectiveness of famciclovir.

Why: Rifampin is a strong inducer of drug‑metabolizing enzymes (notably CYP3A4) and drug transporters. Famciclovir is converted to penciclovir, and rifampin can increase metabolism/clearance of the active drug exposure, leading to lower penciclovir levels.

Practical implication: With concurrent use, antiviral effectiveness may be reduced, so clinicians may:

• choose an alternative antiviral, or
• adjust therapy and monitor closely depending on the indication and regimen.

Important: This interaction is not usually something to manage with simple timing changes—your prescriber should guide the plan.

If you tell me what you’re taking famciclovir for (e.g., herpes zoster/shingles vs. HSV suppression, dose, and your rifampin dose for TB/other use), I can help interpret the likely impact and typical approaches.